EP3484926
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)
:
EP einkaleyfi: Þýðing ekki lögð inn:
17.7.2017:
16.2.2022:
17748642.0
:
16.7.2037
:
HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)
17.7.2017
16.2.2022
:
OGD2 Pharma:
3, chemin du Pressoir Chênaie, 44100 Nantes, FR
:
TERME, Mickaël:
44250 Saint-Brevin-les-Pins, FR
:
LE DOUSSAL, Jean-Marc:
44100 Nantes, FR
:
DORVILLIUS, Mylene:
44100 Nantes, FR
:
ASSOULINE, Brigitte:
92400 Courbevoie, FR
:
16001564:
15.7.2016:
EP
:
EP2017000855:
17.7.2017
:
C07K 16/30, A61P 11/00, A61P 13/12, A61P 15/00, A61P 17/00, A61P 21/00, A61P 25/00, A61P 27/02, A61P 35/00, A61P 35/02